<DOC>
	<DOCNO>NCT01565434</DOCNO>
	<brief_summary>Main objective : investigate whether functional polymorphism CR1 ( length , number binding site C4b C3b , erythrocyte density , rate soluble CR1 ... ) determine genetic acquire , susceptibility factor disease Alzheimer 's .</brief_summary>
	<brief_title>Erythrocyte Complement Receptor 1 Alzheimer Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>caucasian people Alzheimer dementia define DSMIV criterion patient without Alzheimer disease control subject diseases modify CR1 physiology</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>